Schroder Investment Management Group
AVNS

Schroder Investment Management Group’s Avanos Medical AVNS Stock Holding History

Schroder Investment Management Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,730
Closed -$782K – 1326
2017
Q2 		$782K Buy
+19,730
New +$746K ﹤0.01% 1011
2015
Q3 		– Sell
-120,573
Closed -$4.88M – 1175
2015
Q2 		$4.88M Sell
120,573
-1,400
-1% -$62.8K 0.01% 738
2015
Q1 		$5.85M Sell
121,973
-34,894
-22% -$1.62M 0.01% 738
2014
Q4 		$7.13M Buy
+156,867
New +$6.16M 0.01% 719

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Schroder Investment Management Group's AVNS Position: Q3 2017 in Review

Schroder Investment Management Group sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 19,730 shares — an estimated $782K sold.

Schroder Investment Management Group first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $7.13M in Q4 2014. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Schroder Investment Management Group reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 19,730 Avanos Medical shares in Q3 2017, an estimated $782K.
  • Schroder Investment Management Group first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
  • Schroder Investment Management Group's Avanos Medical position peaked at $7.13M in Q4 2014.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Schroder Investment Management Group's 13F filing for Q3 2017, filed 9 Nov 2017.